Evidence map›Paper›PMID 26241860›Full record

ArticlePLoS pathogens2015

The Two-Phase Emergence of Non Pandemic HIV-1 Group O in Cameroon.

Marie Leoz, Felix Feyertag, Anfumbom Kfutwah, Philippe Mauclère, Guillaume Lachenal, Florence Damond, Fabienne De Oliveira, Véronique Lemée, François Simon, David L Robertson and 1 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Microbiology spectrum · 2024
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Marie LeozLaboratoire de Virologie, CHU Charles Nicolle, Rouen, France; EA 2656 GRAM, Université de Rouen, Rouen, France.
Felix FeyertagComputational and Evolutionary Biology, Faculty of Life Sciences, University of Manchester, Manchester, United Kingdom.
Anfumbom KfutwahService de Virologie, Centre Pasteur du Cameroun, Yaoundé, Cameroun.
Philippe MauclèreService de Virologie, Centre Pasteur du Cameroun, Yaoundé, Cameroun; Direction Interarmées du Service de Santé, Nouméa, Nouvelle Calédonie.
Guillaume LachenalLaboratoire SPHERE, UMR 7219, Université Paris Diderot & Institut Universitaire de France, Paris, France.
Florence DamondService de Virologie, APHP CHU Bichat Claude Bernard, Faculté de Médecine Paris Diderot, Paris, France.
Fabienne De OliveiraLaboratoire de Virologie, CHU Charles Nicolle, Rouen, France.
Véronique LeméeEA 2656 GRAM, Université de Rouen, Rouen, France; Laboratoire associé au Centre National de Référence du VIH, CHU Charles Nicolle, Rouen, France.
François SimonService de Microbiologie, APHP CHU Saint Louis, Faculté de Médecine Paris Diderot, Paris, France.
David L RobertsonComputational and Evolutionary Biology, Faculty of Life Sciences, University of Manchester, Manchester, United Kingdom.
Jean-Christophe PlantierLaboratoire de Virologie, CHU Charles Nicolle, Rouen, France; EA 2656 GRAM, Université de Rouen, Rouen, France; Laboratoire associé au Centre National de Référence du VIH, CHU Charles Nicolle, Rouen, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Unlike the pandemic form of HIV-1 (group M), group O viruses are endemic in west central Africa, especially in Cameroon. However, little is known about group O's genetic evolution, and why this highly divergent lineage has not become pandemic. Using a unique and large set of group O sequences from samples collected from 1987 to 2012, we find that this lineage has evolved in successive slow and fast phases of diversification, with a most recent common ancestor estimated to have existed around 1930 (1914-1944). The most rapid periods of diversification occurred in the 1950s and in the 1980s, and could be linked to favourable epidemiological contexts in Cameroon. Group O genetic diversity reflects this two-phase evolution, with two distinct populations potentially having different viral properties. The currently predominant viral population emerged in the 1980s, from an ancient population which had first developed in the 1950s, and is characterized by higher growth and evolutionary rates, and the natural presence of the Y181C resistance mutation, thought to confer a phenotypic advantage. Our findings show that although this evolutionary pattern is specific to HIV-1 group O, it paralleled the early spread of HIV-1 group M in the Democratic Republic of Congo. Both viral lineages are likely to have benefited from similar epidemiological contexts. The relative role of virological and social factors in the distinct epidemic histories of HIV-1 group O and M needs to be reassessed.

Indexed as

Evolution, MolecularCameroonHIV-1HIV InfectionsHumansPhylogenyPolymerase Chain Reaction

Identifiers

PMID26241860
PMCPMC4524642

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.